|
|
HHSN292201500060U
|
$5,878,180
|
N/A
|
CONSTELLATION NEW ENERGY
|
|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-04
|
$165,747
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
(1) Intestinal Organoid Models for APC LOH
|
5R21CA208638-02
|
$192,406
|
GIARDINA, CHARLES
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
2U54CA163071-06
|
$1,427,230
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143727-08
|
$1,188,362
|
PALAFOX, NEAL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
|
5R21CA205636-02
|
$202,275
|
CHEN, GRACE
|
UNIVERSITY OF MICHIGAN
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research
|
5P20CA192988-04
|
$179,686
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
(6) Molecular mechanisms explaining premalignant changes in the etiology of melanoma
|
1R21CA208736-01A1
|
$146,000
|
MURPH, MANDI
|
UNIVERSITY OF GEORGIA
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
1R01CA216248-01
|
$565,675
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
|
5R01CA208526-02
|
$472,047
|
CUCINOTTA, FRANCIS
|
UNIVERSITY OF NEVADA LAS VEGAS
|
|
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
|
1R01CA215802-01
|
$503,309
|
SPARREBOOM, ALEXANDER
|
OHIO STATE UNIVERSITY
|
|
(Diversity supplement to R01CA188096) Targeting autophagaphy in hereditary breast cancer
|
3R01CA188096-03S1
|
$57,707
|
XIA, BING
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
(NSF: 2018 GENERAL SOCIAL SURV) ADDING GLOBAL HEALTH ITEMS TO THE 2018 GENERAL SOCIAL SURVEY
|
APC17004
|
$187,328
|
UNKNOWN, UNKNOWN
|
NATIONAL SCIENCE FOUNDATION
|
|
(PQ #10) Gut-brain interactions underlying chemotherapy-induced behavioral comorbidities
|
1R01CA216290-01
|
$338,903
|
PYTER, LEAH
|
OHIO STATE UNIVERSITY
|
|
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma
|
5R01CA190121-05
|
$362,088
|
VERHAAK, ROELAND
|
JACKSON LABORATORY
|
|
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis
|
1R21CA216304-01
|
$234,900
|
NEWMEYER, DONALD
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
(PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors
|
5R21CA208723-02
|
$177,852
|
BETTEGOWDA, CHETAN
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQ 9) Dysregulation of epidermal MMP-13 as cause of paclitaxel-induced peripheral neuropathy
|
1R01CA215973-01
|
$443,022
|
RIEGER, SANDRA
|
MOUNT DESERT ISLAND BIOLOGICAL LAB
|
|
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation
|
5R01CA208535-02
|
$451,564
|
GROSSHANS, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
|
1R01CA205965-01A1
|
$650,815
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ#9) Promoting Axon Stability to Prevent Therapy-induced Peripheral Neuropathy
|
1R01CA219866-01
|
$445,407
|
DIANTONIO, AARON
|
WASHINGTON UNIVERSITY
|
|
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy
|
1R21CA215985-01
|
$198,000
|
CHANG, KAREN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
5R01CA206025-02
|
$637,172
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ1) Cellular senescence as an initiating event in malignant transformation
|
1R21CA206013-01A1
|
$203,400
|
DAVID, GREGORY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
|
5R01CA205258-02
|
$464,261
|
GUDAS, LORRAINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ1) Epigenetic effects of the premalignant field
|
5R01CA208620-02
|
$372,671
|
TERADA, LANCE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-02
|
$438,499
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
5R01CA206026-02
|
$356,850
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
1R01CA216054-01
|
$324,411
|
HAYDEN, MELANIE
|
STANFORD UNIVERSITY
|
|
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
|
1R01CA206483-01A1
|
$718,958
|
EMU, BRINDA
|
YALE UNIVERSITY
|
|
(PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development
|
1R01CA220551-01
|
$383,749
|
ZHAO, HAOTIAN
|
SANFORD RESEARCH/USD
|
|
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
|
1R01CA219893-01
|
$442,614
|
GHOSH, MOUMITA
|
NATIONAL JEWISH HEALTH
|
|
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer
|
5R01CA205608-02
|
$346,909
|
SCHEET, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ10) Do microbiota alter the epigenetic landscape in human genome
|
5R21CA208464-02
|
$212,063
|
STRONGIN, ALEX
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy
|
5R21CA205644-02
|
$202,439
|
WHITESIDE, THERESA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-02
|
$377,438
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
|
5R21CA206309-02
|
$182,192
|
HARRIS, REUBEN
|
UNIVERSITY OF MINNESOTA
|
|
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
|
1R01CA219880-01
|
$697,539
|
PALUCKA, ANNA KAROLINA
|
JACKSON LABORATORY
|
|
(PQ3) Disruption of immune surveillance by aneuploidy and aberrant MHCII expression
|
1R01CA220009-01
|
$310,000
|
ZANETTI, MAURIZIO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-02
|
$772,521
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
1R01CA216265-01
|
$632,860
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
(PQ3) Immune Modulation of DNA Mismatch Repair in Colorectal Cancer
|
5R01CA206010-02
|
$369,639
|
CARETHERS, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
(PQ3) Modulation of Osteosarcoma Biology by Inflammation and Immunity Defined through a ComparativeApproach
|
5R21CA208529-02
|
$166,388
|
MODIANO, JAIME
|
UNIVERSITY OF MINNESOTA
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-02
|
$518,165
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years
|
5R01CA206477-02
|
$756,373
|
PALEFSKY, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ4) Elucidating Determinants of Susceptibility to Tumorigenesis in the Skin
|
5R21CA208298-02
|
$180,459
|
RAMSEY, MATTHEW
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas
|
5R21CA208463-02
|
$174,000
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
|
5R01CA206465-02
|
$527,068
|
JUSTICE, AMY
|
YALE UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-03S1
|
$57,872
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|